Psychosocial Screening for Neuroendocrine Tumor Patients

Peking University

Status: Unknown

Conditions: Neuroendocrine Tumors

Study type: Observational

Funder types: Other

Identifiers

NCT03372356

PSNET

Details and patient eligibility

About

This is a psychosocial screening application to usual care in a cohort of neuroendocrine tumor patients. The application involves monitoring using the NCCN Distress Thermometer(DT), Hospital Anxiety and Depression Scale(HADS), Self-Perceived Burden Scale(SPBS) and Connor-Davidson Resilience Scale(CD-RISC). These assessments will be completed at baseline, 3 months, 6 months, 12 months and 24 months. Patients will have the option of filling out questionnaires more frequently if desired.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. sign written informed consent form;
2. age ≥ 18 years;
3. pathologically confirmed well-differentiated neuroendocrine tumors, G1-2 (Ki67≤20%);

Exclusion criteria

1. <18 years;
2. Neuroendocrine carcinoma;
3. History of psychiatric or psychologic illness;
4. History of previous cancers or cancer distress;
5. Patients with central nervous system(CNS) disorder；
6. Severe, uncontrolled medical condition that would affect patients' compliance;

Trial design

100 participants in 1 patient group

Neuroendocrine tumors

Description:

Patients with neuroendocrine tumors will be given access to an application that monitors distress, anxiety, depression, self-perceived burden, and resilience at regular intervals for 3 months lasting for 24 months.